Burden and Clinical Impact of Hepatitis D Virus Co-Infection Among HBsAg-Positive Patients in Mauritania
Diseases · 12.02.2026 · 14 (2) · 69
DOI: 10.3390/diseases14020069 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diseases, online erschienen am 12.02.2026. Verfasst von Mohamed Abdawa und 4 weiteren Autor:innen. Beteiligte Einrichtung: Unité d'Épidémiologie Moléculaire et Diversité des Micro-Organismes (EMDM), Université de Nouakchott, Nouakchott, Mauritania. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Hepatitis B virus (HBV) infection remains highly endemic in sub-Saharan Africa, where hepatitis delta virus (HDV) co-infection substantially worsens liver disease outcomes. Mauritania has long been suspected to be a high-burden setting for HBV-HDV co-infection, yet contemporary data describing its clinical and virological impact remain limited.
Methods
We conducted a hospital-based cross-sectional study at the National Institute of Hepato-Virology (INHV) in Nouakchott, including 401 HBsAg-positive patients. Demographic, clinical, biological, and virological data were collected. HDV serology and RNA testing were performed when available. Liver disease severity, including cirrhosis and hepatocellular carcinoma (HCC), was assessed using clinical, biological, and imaging criteria.
Results
HDV antibodies were detected in 31.9% of HBsAg-positive patients, confirming Mauritania as a hyper-endemic area for HDV. HDV co-infection was strongly associated with advanced liver disease, with HDV antibodies present in 86.4% of cirrhotic patients and 82.4% of those with HCC. Patients with HDV infection frequently exhibited suppressed HBV DNA levels, reflecting viral interference. A substantial proportion of patients presented with decompensated cirrhosis or HCC at diagnosis, and nearly 70% were treatment-naïve. Overall, HDV co-infection emerged as the principal driver of severe liver disease in this cohort.
Conclusions
HBV/HDV co-infection is highly prevalent in Mauritania and is associated with a wide clinical spectrum ranging from asymptomatic infection to decompensated cirrhosis and hepatocellular carcinoma. HDV co-infection is the principal driver of severe liver disease, often occurring despite low or undetectable HBV DNA levels. Systematic HDV screening among all HBsAg-positive individuals is urgently needed to improve risk stratification, guide therapeutic decisions, and reduce liver-related morbidity and mortality.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Unité d'Épidémiologie Moléculaire et Diversité des Micro-Organismes (EMDM), Université de Nouakchott, Nouakchott, Mauritania.
- Institut National d'Hépato-Virologie (INHV), Nouakchott, Mauritania.
- Institut National de la Santé et de la Recherche Médicale (INSERM) U1350, 151 Cours Albert Thomas, 69003 Lyon, France.
- HIFIH UFR Santé, Faculté de Médecine, University of Angers, 4 Rue de Larrey, 49933 Angers, France.
ORCID-Profile: Mohamed Abdawa, Isabelle Chemin
Zitieren
APA
Abdawa, M., Hemeyine, M., Chemin, I., Lunel-Fabiani, F., & Mohamed Abdellahi, M. V. (2026). Burden and Clinical Impact of Hepatitis D Virus Co-Infection Among HBsAg-Positive Patients in Mauritania. Diseases, 14(2), 69. https://doi.org/10.3390/diseases14020069
Vancouver
Abdawa M, Hemeyine M, Chemin I, Lunel-Fabiani F, Mohamed Abdellahi MV. Burden and Clinical Impact of Hepatitis D Virus Co-Infection Among HBsAg-Positive Patients in Mauritania. Diseases. 2026;14(2):69. doi:10.3390/diseases14020069
BibTeX
@article{Abdawa2026,
author = {Abdawa, Mohamed and Hemeyine, Mohamed and Chemin, Isabelle and Lunel-Fabiani, Françoise and Mohamed Abdellahi, Mohamed Vall},
title = {Burden and Clinical Impact of Hepatitis D Virus Co-Infection Among HBsAg-Positive Patients in Mauritania},
journal = {Diseases},
year = {2026},
volume = {14},
number = {2},
pages = {69},
doi = {10.3390/diseases14020069}
}
EUVIMED